MERCK Kommanditgesellschaft auf Aktien

Headquarters: Darmstadt, Germany

Employees: 60,334

CEO: Ms. Belen Garijo Lopez M.D.

Market Cap

€64.76 Billion

EUR as of July 1, 2023

US$70.69 Billion

history Market Cap History

MERCK Kommanditgesellschaft auf Aktien market capitalization over time

Evolution of MERCK Kommanditgesellschaft auf Aktien market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of MERCK Kommanditgesellschaft auf Aktien

Detailed Description

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Stocks & Indices

MERCK Kommanditgesellschaft auf Aktien has the following listings and related stock indices.

Stock: FSX: MRK

Stock: XETR: MRK


Stock: MTA: MRK



Frankfurter Strasse 250

Darmstadt, 64293


Phone: 49 6151 72 0

Fax: 49 6151 72 5577